Medizinische Universität Graz - Research portal
Yazdani-Biuki Babak |
Presentations at scientific and public conferences
Dejaco, C; Mueller, T; Zamani, O; Kurtz, U; Egger, S; Passini, JR; Totzauer, A; Eisterer, W; Yazdani-Biuki, B; Schwingenschloegl, T; Peichl, P; Kraus, A; Naerr, G; Rickert, V
Golimumab Improves Work Productivity and Activity As Well As Quality of Life in Patients with Rheumatoid Arthritis (RA), Psoriasis Arthritis (PsA) and Axial Spondyloarthritis (axSpA): Interim Results from a Non-Interventional Study in Austria (Go Active)
ARTHRITIS RHEUMATOL. 2018; 70: -ACR;
[Poster]
Web of Science
Dejacol, C; Mueller, T; Zamani, O; Kurtz, U; Egger, S; Resch-Passini, J; Totzauer, A; Eisterer, W; Yazdani-Biuki, B; Schwingenschloegl, T; Peichl, P; Kraus, A; Naerr, GW; Rickert, V
GOLIMUMAB IMPROVES WORK PRODUCTIVITY AND ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIASIS ARTHRITIS (PSA) AND AXIAL SPONDYLOARTHRITIS (AXSPA): INTERIM RESULTS FROM A NON-INTERVENTIONAL STUDY IN AUSTRIA (GO ACTIVE)
ANN RHEUM DIS. 2018; 77: 598-599.-Congress of the European-League-Against-Rheumatism (EULAR); JUN 13-16, 2018; Amsterdam, NETHERLANDS.
Doi: 10.1136/annrheumdis-2018-eular.2411
[Poster]
Web of Science
FullText
FullText_MUG
Brezinschek, HP; Rainer, F; Brickmann, K; Lunzer, R; Graninger W
EULAR RESPONSE AND B CELL ANALYSIS BY HIGH-SENSITIVE FLOWCYTOMETRY - THE AUSTRIAN B-CELL SURVEILLANCE (ABS) STUDY.
Annals of the Rheumatic diseases2011; -Annual European Congress of Rheumatology EULAR 2011
; May 25 28, 2011; London, United Kingdom.
[Oral Communication]
Zechner, PM; Fuerst, FC; Yazdani-Biuki, B; Brickmann, K; Gretler, J; Stradner, MH; Scheidl, S; Hoffmann, G; Tripolt, N; Graninger, WB
LUNG ULTRASOUND FINDINGS IN PATIENTS WITH RHEUMATOID ARTHRITS, SYSTEMIC SCLEROSIS AND SYSTEMIC LUPUS ERYTHEMATODES
Ann Rheum Dis 2010;69(Suppl3):3092010; 69(s3):309-309.-EULAR; June 16-18,2010; Rome,Italy.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Tripolt, N; Thonhofer, R; Graninger, WB; Brezinschek, HP;
Prevalence of antibodies against toxoplasma gondii in patients treated with anti-tnf-alpha therapy.
[AB0167]2009; 68(3):-EULAR; JUN 10-13, 2009; Copenhagen, DENMARK.
[Poster]
Clar, H; Krippl, P; Renner, W; Langsenlehner, U; Leithner, A; Gruber, G; Hofmann, G; Yazdani-Biuki, B; Langsenlehner, T; Windhager, R
Risk profiling for bone metastasis and breast cancer: the influence of the 1498 C/T polymorphism of the vascular endothelial growth factor (VEGF).
Abstract book of the 22nd EMSOS, 7.O.03.2009; 210--22nd EMSOS-Meeting; MAY 13-16, 2009; Stuttgart, GERMANY.
[Oral Communication]
Knapp, M; Fuerst, FC; Scheidl, S; Tripolt, N; Hofmann, G; Brickmann, K; Stradner, MH; Yazdani-Biuki, B; Graninger, WG; Brezinschek, HP
Successful Therapy of Rheumatoid Pleural Effusion (RPF) with Rituximab - A Case Report
ÖGR Jahrestagung; Nov 20-21,2009; Graz,Austria. 2009.
[Poster]
Knapp, M; Fuerst, FC; Stradner, M; Lutfi, A; Brickmann, K; Yazdani-Biuki, B; Hofmann, G; Schaffler, GJ; Graninger, WB
Pilotstudy to compare erosive osteoarthritis (EOA) and arthritis psoriatica (PsA)patients using MRI Tesla 1.5 as an imaging tool
Österreichische Gesellschaft für Rheumatologie Jahrestagung; NOV 21-22,2009; Graz,Austria. 2009.
[Poster]
KNAPP, M; FUERST, FC; STRADNER, M; LUTFI, A; BRICKMANN, K; YAZDANI-BIUKI, B; HOFMANN, G; SCHAFFLER, GJ; GRANINGER, WB
PILOTSTUDY TO COMPARE EROSIVE OSTEOARTHRITIS (EOA) AND ARTHRITIS PSORIATICA (PSA) PATIENTS USING MRI TESLA 1.5 AS AN IMAGING TOOL
ÖGR Jahrestagung; Nov 20-21,2009; Graz,Austria. 2009.
[Poster]
Knapp, M; Gruber, G; Stradner, MH; Fürst, FC; Lutfi, A; Brickmann, K; Yazdani-Biuki, B; Schaffler, GJ
PILOTSTUDY TO COMPARE EROSIVE OSTEOARTHRITIS (EOA) AND ARTHRITIS PSORIATICA (PSA) PATIENTS USING MRI TESLA 1.5 AS AN IMAGING TOOL.
Osteoarthritis and Cartilage2009; 17(S):S209-S209.-OARSI; SEP 10-13, 2009; Montreal, CANADA.
[Poster]
Thonhofer, R; Siegel, C; Trummer, M; Brickmann, K; Yazdani-Biuki, B; Graninger, WB;
Paraspinal Calcification causes back pain in Crest-Syndrom - a case Report.
[AB0408] Ann Rheum Dis2009; 68(3):-EULAR; JUN 10-13, 2009; Copenhagen, DENMARK.
[Poster]
yazdani-biuki, B; Brickmann, K; Fuerst, FC; Tripolt, N; Graninger, WB; Brezinschek, HP;
Assesment of disease activity in patients with rheumatoid arthritis with a modified disease score with fibrinogen.
[THU146] Ann Rheum DIs2009; 68(3):-EULAR; JUN 10-13, 2009; Copenhagen, DENMARK.
[Poster]
Zechner, PM; Fuerst, FC; Tripolt, N; Yazdani-Biuki, B; Hofmann, G; Graninger, WG
Lung ultrasound findings in patients with Rheumatoid Arthrits, Systemic Sclerosis and Systemic Lupus Erythematodes
Österreichische Gesellschaft für Rheumatologie Jahrestagung 2009; NOV 21-22,2009; Graz,Austria. 2009.
[Poster]
Fuerst, F; Stradner, M; Gruber, G; Angerer, H; Setznagel, D; Yazdani-Biuki, B; Windhager, R; Graninger, W
Treatment with 5-AZA-deoxy-cytidine in human arthritic cartilage cells increases the gene expression of MMP-13, BMP-1, chondromodulin-1 and ELK-1.
ANN RHEUM DIS. 2008; 67: A40-A41.-EULAR; Paris, FRANCE.
[Poster]
Web of Science
Fuerst, F; Yazdani-Biuki, B; Gruber, G; Stradner, M; Graninger W;
Increase of gene expression of chondromodulin I and ELK 1 in Human arthrotic cartilage cells after the treatment with 5-AZA-DEOXY-CYTIDINE.
[AB0087]2008; 67(3):-EULAR; JUN 11-14, 2008; Paris, FRANCE.
[Poster]
Fuerst, FC; Glehr M,Lohberger B,Walzer S,Stradner M,Yazdani-Biuki B,Windhager R,Graninger W
Decrease in Growth Rat
CRC ; May 8th 2008 ; Pargue. 2008.
[Oral Communication]
Fuerst, FC; Gruber, G; Angerer, H; Stradner, MH; Setznagel, D; Hofmann, G; Brickmann K; Tripolt N, Yazdani-Biuki, B; Windhager, R; Graninger, WB
Increase of Gene Expression of Chondromodulin I and ELK 1 in human arthrotic cartilage cells after the Treatment with 5-AZA-deoxy-cytidine.
Annals of the Rheumatic Diseases. 2008; 67(S I):5-5.-28TH European Workshop for Rheumatology Research (EWRR) ; FEB 28-MAR 1; Toulouse, FRANCE. (ISBN: 0 )
[Poster]
Brickmann, K; Yazdani-Biuki, B; Holzer, I; Graninger, WB; Brezinschek, HP;
Significant Elevation of Matirx Metalloproteinases 8 and 9 in the synovial fluid of patients with rheumatoid arthritis or gout.
[AB0851] Ann Rheum Dis2007; 66(3):-EULAR; JUN 13-16, 2007; Barcelona, SPAIN.
[Poster]
Brickmann, K; Yazdani-Biuki, BJ; Eibinger, C; Graninger, WB; Brezinschek, HR
Determination of rheumatoid factors (RF) and anti cyclic citruillinated peptide antibodies (anti-CCP) in synovial fluid provides no additional information
ANN RHEUM DIS. 2007; 66: 561-561.-EULAR Annual Scientific Meeting; JUN 13-16, 2007; Barcelona, SPAIN.
[Poster]
Web of Science
Brickmann, KS; Yazdani-Biuki, BJ; Brezinschek, RI; Graninger, WB; Brezinschek, HP
Sequential etanercept and rituximab therapy in patients with active RA-SERRA
ARTHRITIS RHEUM. 2007; 56(12):4278-4278.-ACR Annual Scientific Meeting; NOV 6-11, 2007; Boston, USA.
[Poster]
Web of Science
Brickmann,K; Yazdani-Biuki, B.J; Graninger, W.B; Brezinschek H.P;
Significant elevation of angiogenic factors in synovial fluid of RA-Patients.
[AB0029]. 2007; 66(3):-EULAR; JUN 13-17,2007; Spain.
[Poster]
Clar, H; Krippl, P; Renner, W; Langslehner, U; Leithner, A; Gruber, G; Hofmann, G; Yazdani-Biuki, B; Langslehner, T; Windhager, R;
Risk profiling for bone metastasis and breast cancer: the influence of the 1498 C/T polymorphism of the vascular endothelial growth factor (VEGF).
Abstract book of the 20th Annual EMSOS Meeting 2007; 54:OP7.1.2007; -20th Annual EMSOS Meeting; May 17-18, 2007; Porto, PORTUGAL.
[Oral Communication]
Clar, H; Leithner, A; Krippl, P; Renner, W; Langslehner, U; Gruber, G; Hofmann, G; Yazdani-Biuki, B; Langslehner, T; Windhager, R;
Risk profiling for bone metastases and breast cancer: the influence of the GNB3 825C>T polymorphism.
Abstract book of the 20th Annual EMSOS Meeting 2007; 55:OP7.1.; -20th Annual EMSOS Meeting; May 17-18, 2007; Porto, PORTUGAL.
[Oral Communication]
Fuerst, F;Gruber G;Yazdani-Biuki, B;Stradner, MH; Kastner, N; Setznagl, D;Stadlmeyer, E;Windhager, R; Graninger, WB
DECREASE OF COLLAGEN TYPE II EXPRESSION IN HUMAN CARTILAGE CELLS AFTER THE TREATMENT WITH 5 AZA DEOXY CYTIDINE.
Osteoarthritis and Cartilage2007; 15(SupB):C129-C129.-OARSI; DEC 6-9, 2007; Fort Lauderdale, USA. (ISBN: 1063-4584 )
[Poster]
Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P
A multigenic approach to predict breast cancer risk.
Supplement 121; 157(25):14-14.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, Austria.
[Poster]
Gruber, G;Fuerst, FC;Yazdani-Biuki, B;Stradner, MH; Clar, H; Setznagel, D;Angerer, H;Graninger WB;Windhager, R
INCREASE IN THE GENE EXPRESSION OF MMP 13 AND BMP 2 IN HUMAN ARTHROTIC CARTILAGE CELLS AFTER THE TREATMENT WITH 5 AZA DEOXY CYTIDINE.
Osteoarthritis and Cartilage. 2007; 15(SupB):C122-C123.-OARSI; DEC; Fort Lauderdale, USA.
[Poster]
Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Yazdani-Biuki, B; Renner, W; Fürst, F; Samonigg, H; Krippl, P; Langsenlehner, U
Classification tree analysis of functional genetic polymorphisms predicts breast cancer risk
Onkologie2007; 30(S 3):52-52.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel, SWITZERLAND. (ISBN: 978-3-8055-8431-9 )
[Oral Communication]
Brezinschek, H; Brickmann, K; Yazdani-Biuki, B; Graninger, W
Sequential Rituximab and Etanercept Treatment in two patients with rheumatoid arthritis
Journal für Mineralstoffwechsel . 13(4):121-121.-Jahrestagung der ÖGR; NOV 24-15, 2006; Vienna, AUSTRIA.
[Poster]
Brezinschek, HP; Dörner, T; Brezinschek, R; Brickmann, K; Yazdani-Biuki, B; Graninger, WB;
Successful sequential rituximab and etanercept treatment in two patients with rheumatoid arthritis.
[AB0173] Ann Rheum Dis2006; 65(3):-EULAR; JUN 21-24, 2006; Amsterdam, NETHERLANDS.
[Poster]
Brickmann, K; Brezinschek, H; Yazdani-Biuki, B; Graninger, W
Prevalence of Anti-citrullinated mutated vimentin (MVC)
Journal für Mineralstoffwechsel . 13(4):121-121.-Jahrestagung der ÖGR; NOV 24-25, 2007; Vienna, AUSTRIA.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Brezinschek, H; Graninger, W
Elevated VEGF Levels in synovial fluid of patients with rheumatoid arthritis or gout.
Journal für Mineralstoffwechsel . 13(4):122-122.-Jahrestagung der ÖGR; NOV 24-25, 2007; Vienna, AUSTRIA.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Brezinschek, H; Graninger, W
Autoantibodies against mutated citrullinated vimentin (Anti-MCV) in the elderly population
Journal für Mineralstoffwechsel . 14(3):122-122.-Jahrestagung der ÖGR; NOV 24-25, 2007; Vienna, AUSTRIA.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Mueller, T; Graninger, WB; Brezinschek, HP;
Anti-mutated-citrullinated-vimentin antibodies (MCV) in psoriatic arthritis.
[AB0492] Ann Rheum Dis2006; 65(3):-EULAAR; JUN 21-24, 2006; Amsterdam, NETHERLANDS.
[Poster]
Brickmann, KP; Yazdani-Biuki, BJ; Graninger, M; Brezinschek, RI; Stoiser, E; Graninger, WB; Brezinschek, HP
Autoantibodies against mutated citrullinated Vimentin (anti-MCV) in the elderly population
ANN RHEUM DIS. 2006; 65: 580-581.-Annual European Congress of Rheumatology (EULAR 2006); JUN 21-24, 2006; Amsterdam, NETHERLANDS.
Web of Science
Hermann, J; Mueller, TH; Yazdani-Biuki, B; Graninger, W
Impact of TNF-blocker therapy on disease activity, function and health status in ankylosing spondylitis in the community
Clin Exp Rheumatol. 24(4):484-484.-V International Congress on Spondylarthropathies; 12-14.10.2006; Gent. (ISBN: 0392-856X )
[Poster]
Hermann, J; Müller, T; Yazdani-Biuki, B; Graninger, W
Einfluss der TNF-Blocker auf den Gesundheitszustand der Patienten mit ankylosierender Spondylitis in der Bevölkerung
Journal für Mineralstoffwechsel . 13(4):130-130.-Jahrestagung der ÖGR; NOV 24-25, 2007; Vienna, Austria.
[Poster]
Hermann, J; Müller, Th; Yazdani-Biuki, B; Graninger, W
Einfluss der Einführung von TNF-Blocker auf den Gesundheitszustand der Patienten mit ankylosierender Spondylitis in der Bevölkerung
Wiener Medizinische Wochenschrift Skriptum. 3(11):14-15.-Jahrestagung der ÖGR; 24.-25.11.2006; Wien. (ISBN: 1613-3803 )
[Poster]
Yazdani-Biuki, BJ; Brickmann, K; Brezinschek, RI; Muller, T; Graninger, W; Brezinschek, H
The positive predictive value of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis compared with psoriatic arthritis and chronic lymphocytic B-cell leukemia
ANN RHEUM DIS. 2006; 65: 159-159.-Annual European Congress of Rheumatology (EULAR 2006); JUN 21-24, 2006; Amsterdam, NETHERLANDS.
Web of Science
Brickmann, K;Brezinschek, R; Yazdani-Biuki;B; Brezinschek, HP; Demel, U; Graninger, W;
Rheumatoid Arthritis-specific Autoantibodies in chronic lymphatic B-Cell Leukemia.
[AB0077] 2005; 64(3):-EULAR; JUN 8-11,2005; Vienna, AUSTRIA.
[Poster]
Brickmann, KS; Yazdani-Biuki, BJ; Brezinschek, RI; Mulabecirovic, A; Graninger, WB; Dorner, T; Brezinschek, H
Different reading frame usage of variable heavy chain diversity segments in patients with systemic lupus erythematosus and rheumatoid arthritis
ANN RHEUM DIS 2005 64: 229-229.
[Poster]
Web of Science
Mueller, T; Graninger, WB; Yazdani-Biuki,B; Breinschek, HP; Pilger, E; Brodmann, M;
Is high sensitive C-reactive protein or coeruloplasmin helpful in the diagnosis of giant cell arthritis?.
[AB0170] Ann Rheum Dis2005; 64(3):-EULAR; JUN 8-11, 2005; Vienna, AUSTRIA.
[Poster]
Yazani-Biuki, B; Brezinschek, R; Brickmann, K; Brodmann, M; Pilger, E; Graninger, WB; Brezinschek, HP;
Diminished growth Factor levels in connective tissue disorders compares to Osteoarthritis.
[AB0192] Ann Rheum Dis2005; 64(3):-EULAR; JUN 8-11, 2005; Vienna, AUSTRIA.
[Poster]
Yazdani-Biuki, BJ; Mueller, T; Brezinschek, H; Graninger, WB; Pilger, E; Brodmann, M
Seasonal variation in acute phase proteins in patients with primary Raynaud's phenomenon
ANN RHEUM DIS 2005 64: 300-300.
[Poster]
Web of Science
Hermann, J; Mueller, T; Yazdani-Biuki, B; Graninger, W
Disease activity and functional impairment of patients with ankylosing spondylitis in Austria - An epidemiologic survey
ANN RHEUM DIS 2004 63: 395-396.
[Poster]
Web of Science
Mueller, T; Hermann, J; Yazdani-Biuki, B.J; Wohlfahrt, K; Brezinschek, H.P; Mulabecirovic,A; Demel, U; Graninger, WB;
ANA Development following treatment with three different tumour necrosis factor alpha-blocking agents.
[AB0072]2004; 63(3):-EULAR; JUN 9-12; 2004; Berlin, GERMANY.
[Poster]
Yazdani-Biuki, B; Wohlfahrt, K; Mueller, T; Mulabecirovic, A; Brezinschek, RI; Graninger, WB; Brezinschek, HP
A modified disease activity score with fibrinogen as a tool for the assesment of disease activity in patients with rheumatoid arthritis
ARTHRITIS RHEUM 2004 50: S164-S164.
Web of Science
Yazdani-Biuki, BJ; Mulabecirovic, A; Mueller, T; Hermann, J; Graninger, WB; Brezinschek, H
Significant increase of IGG- and IGA-rheumatoid factor in patients with rheumatoid arthritis during prolonged treatment with etanercept
ANN RHEUM DIS 2004 63: 140-140.
[Poster]
Web of Science
Mulabecirovic, A; Yazdani-Biuki, B; Brezinschek, R; Muller, T; Hermann, J; Brezinschek, HP
Superantigen seems to shape the naive synovial tissue B cell repertoire in rheumatoid arthritis
ANN RHEUM DIS 2003 62: 141-141.
Web of Science
Muller, T; Liebscher, B; Yazdani-Biuki, B; Eder, S; Gretler, J; Brezinschek, H; Hermann, J
Efficacy and safety of leflunomide in rheumatoid arthritis patients treated in an outpatient clinic
ANN RHEUM DIS 2003 62: 423-423.
Web of Science
Stadlmaier, E; Yazdani-Biuki, B; Hermann, J
Influence of a therapy with tumor necrosis factor alpha inhibiting substances on B cell function in rheumatoid arthritis
ANN RHEUM DIS 2003 62: 174-174.
Web of Science
Yazdani-Biuki, B; Bahadori, B; Mulabecirovic, A; Brezinschek, R; Brezinschek, HP
Isoprostane as a marker of disease activity in SLE patients.
ARTHRITIS RHEUM 2003 48: 1488-1488.
Web of Science
Yazdani-Biuki, B; Brezinschek, RJ; Gretler, J; Eder, S; Mueller, T; Hermann, J; Mulabecirovic, A; Krappinger, A; Stadlmaier, E; Uitz, E; Brezinschek, HP
Comparison of antibody titers with sledai, modified SLEDAI and ECLAM in SLE patients
ANN RHEUM DIS 2003 62: 435-435.
Web of Science
Mueller, TJ; Hermann, J; Fahrleitner, A; Yazdani-Biuki, B; Dimai, HP
Effects of the anti-TNF-antibody infliximab on markers of bone turnover in patients with rheumatoid arthritis.
ARTHRITIS RHEUM. 2001; 44(9): S232-S232.
Web of Science
Yazdani-Biuki, B; Brezinschek, R; Dorner, T; Jakobi, AM; Hermann, J; Muller, T; Eder, S; Gretler, J; Fuchshofer, A; Brezinschek, HP
Naive B cells in SLE preferentially utilize diversity gene segments in reading frames encoding hydrophobic amino acids
J RHEUMATOL. 2001; 28: 87-87.
Web of Science
Yazdani-Biuki, BJ; Brezinschek, RI; Doerner, T; Jakobi, AM; Maizen, C; Brezinschek, HP
Preferential utilization of D segments in hydrophobic reading frames in antibodies is a specific feature of SLE but not RA or normal B-cells.
ARTHRITIS RHEUM. 2001; 44(9): S76-S76.
Web of Science